Surgical resection of pulmonary metastases is an established
|
|
- Caren Harmon
- 5 years ago
- Views:
Transcription
1 Long-Term Results After Pulmonary Resection of Renal Cell Carcinoma Metastases Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W. Wichmann, MD, Rudolf Hatz, MD, Friedrich Wilhelm Schildberg, MD, and Heinrich Fuerst, MD Department of Surgery and Thoracic Surgery, Klinikum Grosshadern, Ludwig-Maximilia-University Munich, Munich, Germany Background. Until now no conclusive data exist regarding the factors influencing long-term survival after pulmonary resection of renal cell carcinoma metastases. The aim of the present study, therefore, was to discover definitive prognostic factors for survival using a large and homogeneous single center patient cohort. Methods. Between 1980 and 2000, 105 patients, after curative resection of lung metastases from renal cell carcinoma, were followed in this long-term study. These patients underwent a total of 150 surgical procedures. analysis was done using the Kaplan-Meier method and the log-rank test. Multivariate analysis of prognostic factors was performed using the Cox multivariate proportional hazard model. Results. Median survival after curative resection reached 43 months (range, 1 to 218 months). at 3, 5, and 10 years was 54%, 40%, and 33%, respectively. Univariate analysis revealed that a complete resection, a less than 4-cm diameter of the metastases and tumor-free lymph nodes at the time of primary operation, were highly significant dependent prognostic factors (p < 0.001). These factors were also shown to be independent prognostic factors as suggested by multivariate analysis (p < 0.05). Conclusio. The size of the metastatic nodule, the completeness of pulmonary resection, and the lymph node status at the time of nephrectomy are the most important prognostic factors that influence survival after resection of pulmonary metastases. Recurrence of resectable pulmonary metastases does not impair survival, thus favoring repeated resection in patients with recurrent disease. (Ann Thorac Surg 2002;73:1082 7) 2002 by The Society of Thoracic Surgeo Surgical resection of pulmonary metastases is an established treatment modality in patients with metastatic disease. Metastases of primary tumors that do not respond well to chemotherapy, radiotherapy, or a combination of both therapies are especially best suited for surgical resection. Renal cell carcinoma is known to belong to this category of malignant disease. To date, reports in the literature do not adequately discern those factors that may have the highest impact on long-term survival after resection of lung metastases in renal cell carcinoma. A major problem of most studies is that the number of patients included does not allow for a proper statistical evaluation. A second problem is that patients with different primary tumors are recruited for these follow-up studies. The analysis of factors of possible prognostic relevance for survival is therefore questionable, as the different biological aspects of certain tumors were not coidered in these studies [1, 2]. The present study, therefore, aimed to define prognostic factors that are of significant relevance for long-term survival after resection of pulmonary renal cell carcinoma metastases in a homogeneous and large single center patient series. Accepted for publication Dec 3, Address reprint requests to Dr Piltz, Department of Surgery and Thoracic Surgery, Klinikum Grosshadern, Ludwig-Maximilia-University Munich, Marchioninistrasse 15, D Munich, Germany; spiltz@ gch.med.uni-muenchen.de. Patients and Methods Between January 1980 and January 2000, a total of 105 patients (73 men, 32 women) underwent thoracotomies for curative resection of pulmonary renal cell carcinoma metastases at our Department of Surgery. A total of 150 procedures were performed on these patients. The mean time period between the primary procedure on the kidney and pulmonary metastasectomy was 59 months. The median patient age at the time of metastasectomy was 59 years, with a range from 35 to 78 years. Histopathologic evaluation of the resected specime revealed true renal cell carcinoma metastases in all patients. Complete resection for cure was defined as follows: the lung is the unique site of metastasis, no additional extrapulmonary sites of metastatic disease or locoregional recurrence in the preoperative examinatio exist (roentgenogram, thoracic computed tomographic scan, ultrasound, or abdominal computed tomographic scan). Furthermore, no macroscopic tumor tissue is left behind and the tumor is not opened. Finally, tumor-free resection margi are required. The following factors of potential prognostic significance were selected for statistical analysis: age, gender, diameter of the largest resected lung metastasis, TNM classification, tumor grading, number of lung metastases in each patient, and disease-free interval. Disease-free interval was defined as time period between curative 2002 by The Society of Thoracic Surgeo /02/$22.00 Published by Elsevier Science Inc PII S (01)
2 Ann Thorac Surg PILTZ ET AL 2002;73: PULMONARY RESECTION OF RENAL CELL CARCINOMA METASTASES 1083 primary operation on the kidney and first detection of a local recurrence or metastatic disease. To evaluate the impact of complete surgical resection we compared our 105 patients with 17 patients undergoing operation without curative intention during the same period. The reason for incomplete resection in these patients was that microscopic (n 3) or macroscopic (n 8) amounts of malignant tissue were being left behind. Three operatio with palliative intention (eg, for treatment of metastasis-related pneumonia) and three exploratory thoracotomies were done. Except for the calculation of the impact of completeness, statistical analyses are based on data obtained in patients treated for cure. Follow-up was based on data provided by the Munich tumor register, by the regional general practitioners, as well as the hospitals participating in the Munich tumor center. All patients or their families were contacted by phone every second year. Statistical analysis was done with the Kaplan-Meier method and the log-rank test [3, 4]. Multivariate analysis of prognostic factors was performed using the Cox multivariate proportional hazard model [5]. A p value less than 0.05 was coidered statistically significant. Results At the last follow-up evaluation (January 2000) 48 of the 105 patients were still alive (46%). Median survival was 99 months (range, 6 to 248 months) after resection of the primary renal cancer and 61 months after pulmonary metastastectomy. Fifty-seven patients had died after a median time period of 50 months after removal of their renal tumor and 19 months after resection of the pulmonary metastasis. All patients but one had died because of progressive renal cancer. Operative Procedures Sixty-eight patients underwent unilateral thoracotomy for metastases that only affected one side and 28 patients with metastases on both sides had two sequential thoracotomies, within a time interval ranging from 2 to 6 weeks. Metastases on both sides were removed by midline sternotomy in 8 patients. In 1 patient exploration of the contralateral side was performed through a sternotomy, despite not having any preoperative proof of metastatic disease on both sides. This exploration did not reveal a malignant lesion. One hundred fifty procedures were performed on 105 patients. Of these procedures, 118 were performed as wedge resectio (79%), in 9 patients as segmental resectio, and in 23 major resectio (19 lobectomies and 4 bilobectomies) were necessary. All patients undergoing resection for cure were operated on through an open thoracotomy. Number of Resected Metastases Forty-nine patients (47%) had a single lung metastasis, 14 patients had two metastases, 12 had three metastases, and 30 patients had more than three metastases. The median number of metastases resected was two. One patient in whom 32 histologically confirmed metastases were resected (20 on the right side, 12 on the left side) survived pulmonary metastasectomy for 132 months, and at his last clinical follow-up evaluation no metastases were detected. Complicatio In 16 procedures (of 150, 10.7%), a complication was observed. One patient had a rethoracotomy for postoperative bleeding from the chest wall, and 1 patient hemorrhaged and required a blood trafusion but no additional procedure. Three patients were reintubated because of respiratory iufficiency and one had prolonged respiratory support for more than 12 hours. Atelectasis occurred in 2 patients and required bronchoscopic clearance. Five patients had superficial wound infection that was resolved under local wound therapy. After a thoracotomy on the left side, 1 patient suffered from paralysis of the recurrent nerve. One patient (1 of 105; 0.95%) died at 34 days from severe sepsis after a lower bilobectomy and angioplastic resection of the pulmonary vein and a subsequent pleural empyema. Adjuvant Treatment Regime Additional nourgical adjuvant treatment was administered to 44 patients (42%). Eighteen patients had radiotherapy alone. In 2 patients radiotherapy was combined with chemotherapy and immunotherapy and 1 patient underwent chemoradiation. Seven patients were treated with chemotherapy only. A combined chemotherapy and immunotherapy was administered to 5 patients and another 11 patients received immunotherapy only. Twelve percent (13 of 105) of all of the study patients underwent rethoracotomy. In 1 patient a thoracotomy was performed six times. The median time period until recurrence of pulmonary metastases was 10 months. The median survival time of patients who underwent a rethoracotomy was 46 months, which is longer than survival for patients after a single metastastectomy (median survival, 40 months). The difference, however, did not reach statistical significance. Statistical Analysis The results of the univariate analysis are shown in Table 1. Highly significant differences (p 0.001) were found for the following measures: complete versus incomplete resection of the metastases (Fig 1); size of the metastasis ( 4 cm versus 4 cm); and lymph node status at the time of the primary renal operation (Fig 2). Significant differences (p 0.05) were observed for the number ( 2 versus 2; Fig 3) and the size ( 2 cm versus 2 cm; Fig 4) of the metastases. As shown in Table 1, other factors were found not to be significant. Multivariate analysis revealed that complete and incomplete resection of pulmonary metastasectomy (p ; relative risk 3.56; odds ratio 1.61 to 7.83) as well as the lymph node status at the time of primary tumor operation (pn) (p 0.031; relative risk 1.56; odds ratio 1.04 to 2.34) are independent prognosis factors. If only patients resected for cure are coidered (n 105) lymph node status at the time of primary operation (pn) (p
3 1084 PILTZ ET AL Ann Thorac Surg PULMONARY RESECTION OF RENAL CELL CARCINOMA METASTASES 2002;73: Table 1. Univariate Analysis of Prognostic Variables for Factor 0.049, relative risk 1.61; odds ratio 1.0 to 2.59) and the size of the metastasis (p ; relative risk 2.42; odds ratio 1.40 to 4.20) are independent prognostic factors. Comment p Value Complete resection a Sex Number of lesio Diameter 2 cm Diameter 3 cm Diameter 4 cm Disease-free interval pt pn pm Grade a Analysis based on 105 complete and 17 incomplete resected patients. not significant. The selection of patients with metastatic disease to the lung who will profit from pulmonary metastasectomy and subsequently show a significant improvement in the survival rate is still a major issue of thoracic surgery. Some patients are refused proper surgical therapy, or the operation performed is not radical enough, whereas others are overtreated and the indication for operation is exaggerated. It appears that more than 50% of the patients with lung metastases originating from sarcomas, germ-line tumors, and pediatric tumors are coidered for metastasectomy; such a broad indication for surgical treatment does not seem to exist for pulmonary metastases from epithelial tumors [6]. Preoperative diagnostic assessment must analyze functional operability of the patient as well as curative resectability of the metastases. Our data clearly indicate that, after pulmonary metastasectomy, residual tumor tissue prohibits long-term survival and there is no obvious benefit for the patient. The same holds true for extended resectio (eg, partial resection of the chest wall or the diaphragm) where the tumor has to be completely resected and must not be opened. In our series none of the 17 patients with incomplete resection lived longer than 29 months as opposed to 62% of the patients after complete resection, who were still alive at that time. These data confirm the results of other investigators, who also observed significant survival benefits only for patients with complete resection of lung metastases [7, 8]. On the basis of our findings we cannot recommend video-assisted thorascopic surgery for metastases if curative resection is intended. Sufficient palpation of the lung in atelectasis cannot be guaranteed using thoracoscopic techniques that can result in a higher risk of missing the smaller lesio. In a prospective study Loehe and colleagues [9] demotrated that even if a helical computed tomographic scan is used before operation one-third of all patients still suffer from additional undetected malignant lesio. These findings are also supported by other studies [6, 7, 10 12]. In the future, intraoperative ultrasound may prove to be sufficient for the detection of additional metastases that were not seen on preoperative computed tomographic sca. It is not generally accepted among thoracic surgeo to principally explore both lungs if metastases are discovered preoperatively only on one side [6, 7]. For the time being, we do not routinely perform bilateral exploration in patients with metastases from renal carcinoma as opposed to patients suffering from germ-line tumors or sarcomas. Ten of the 13 patients who underwent repeated thoracotomies suffered from ipsilateral recurrence, two recurrences were contralateral and one was bilateral. Our findings indicate that in most patients (11 of 13) recurrent metastases are found on the side that had already been completely explored during the previous operation. The survival data reported here (Table 2) support the notion that exploration may be limited to the Fig 1. Probabiltity of survival of the patients undergoing curative (n 105) and incomplete pulmonary resection (n 17) of renal cell carcinoma metastases. Zero on the x-axis represents the date of the first pulmonary resection (p 0.001). (pat. patients.)
4 Ann Thorac Surg PILTZ ET AL 2002;73: PULMONARY RESECTION OF RENAL CELL CARCINOMA METASTASES 1085 Fig 2. Probability of survival after complete resection according to involvement of regional lymph nodes (pn) at the time of primary renal operation. Patients with tumorfree lymph nodes have a highly significant better survival rate (p 0.001) than patients with regional (local) lymph node metastases. (pat. patients.) affected side in patients with metastases from renal cancer. Until now, there is no report in the literature that a bilateral exploration performed in every patient may lead to an improvement in rate of survival. Furthermore, unnecessary thoracotomy leads to adhesio and radiologic artifacts that could limit the seitivity and specificity of diagnostic tools such as computed tomographic sca during follow-up. Our observatio indicate that patients with a maximum metastasis diameter larger than 2 cm had a significantly shorter survival rate than did patients with smaller metastases. In a report by Cerfolio and associates [7], it was found that the size of the metastasis was of no prognostic significance. In an earlier study from the same group, Jett and colleagues [13] reported a significantly increased survival rate in patients with metastases larger than 3 cm. These reports are not in agreement with our observation that larger size metastases have a significant influence on long-term survival and this becomes even more obvious with metastases larger than 4 cm (p 0.001). A number of studies [6, 7, 14, 15] have shown cut-off values for disease-free interval ranging between 20 and 36 months with significantly improved survival in patients with a longer disease-free interval. In our series we were unable to confirm this effect of disease-free interval on survival. Two recent reports [8, 16] appear to support our results. Nonetheless, there is only one study that reports findings in a cohort with the same sample size and homogeneity as reported here [7]. Interestingly, we observed a significant relation between the existence of lymph node metastasis at the time of removal of the primary tumor and long-term survival. Multivariate analysis revealed that lymph node metastases at the time of primary cancer resection is an independent prognostic factor. A similar trend was observed by Fourquier and co-workers [8] in an earlier study. Due to the small patient number in this study the difference in Fig 3. Probability of survival after complete resection in relation to the number of resected pulmonary metastases (p 0.029). (pat. patients.)
5 1086 PILTZ ET AL Ann Thorac Surg PULMONARY RESECTION OF RENAL CELL CARCINOMA METASTASES 2002;73: Fig 4. Probability of survival after complete resection in selection to the largest diameter of the resected pulmonary lesion. Patients with a metastasis smaller than 2 cm have a significantly better survival rate (p 0.008). (pat. patients.) survival did not reach statistical significance. These data confirm an autopsy study [17] of 554 perso in whom renal carcinoma had remained undiagnosed during their lifetimes. In 88 patients renal cancer was the cause of death. Lymphatogenous dissemination was detected in 91% of all these patients and 85% had additional, mostly multifocal metastatic spread. Therefore, it appears that tumors that metastasize into the lung through the bloodstream alone display better tumobiologic behavior than tumors that also metastasize by way of the lymphatics. Because the nodal status is a routine measure of primary cancer resection it should be coidered in the decisionmaking process regarding operation for recurrent disease. Univariate analysis of our data shows that the absolute number of resected metastases is a relevant prognostic factor. Patients with up to two metastases survived significantly longer than all other patients. Until now, only a few researchers analyzed the prognostic impact of the number of metastases being resected during operation. Most reports [7, 8, 13] limit their analysis to subgroups of patients with solitary versus multiple lesio. Our findings support the notion that differentiation into only two groups is not sufficient. Furthermore, our data confirm the observation of other investigators [6 8, 14] who report that repeated curative lung resection in patients with recurrent disease is of benefit to the patient and that survival is not adversely affected by removal of recurrent metastases. Adjuvant treatment regime in this study did not seem to have a significant impact on survival. However, in our study the number of patients allocated into each single adjuvant treatment group was too small to allow for comparison between treatment groups. In summary, the long-term follow-up data after resection for pulmonary renal carcinoma metastases indicate satisfying survival rates and, therefore, support an aggressive surgical approach in this particular metastatic disease. In contradiction to earlier studies that reported no cure after metastasectomy in renal cell carcinoma the present analysis supports the contention that a cure is possible [18]. In view of the low perioperative morbidity and mortality rates and due to the lack of appropriate treatment alternatives we therefore recommend that metastasectomy should be performed whenever possible. In patients with unilateral distribution renal cell carcinoma metastases it appears safe to refrain from bilateral exploration. If the metastatic lesio cannot be completely resected, operation should only be performed in selected patients. Table 2. Following Resection of Lung Metastases of Renal Cell Carcinoma Reference Year No. of Patients Median (mo) 3-Year 5-Year 10-Year Discrimination complete versus incomplete Morrow [2] %... No Jett [13] (45%) 27%... No Pogrebniak [19] (60%) (60%)... Yes Cerfolio [7] (57%) 36% 14% Yes Fourquier [8] (48) (60%) 44% 4% Yes Kavolius [20] %... Yes Friedel [21] (50%) 39% 21% Yes Present series % 40% 33% Yes () as estimated by Kaplan-Meier analysis.
6 Ann Thorac Surg PILTZ ET AL 2002;73: PULMONARY RESECTION OF RENAL CELL CARCINOMA METASTASES 1087 We thank Rolf Weitkunat for his expert support in statistical analysis of our data. Furthermore, we are grateful for the superb editorial assistance of Margy Lynch (MSU, East Laing, MI). References 1. Schildberg FW, Meyer G, Piltz S, Koebe HG. Surgical treatment of tumor metastases: general coideratio and results. Surg Today 1995;25: Morrow CE, Vassilopoulos PP, Grage TB. Surgical resection for metastatic neoplasms of the lung: experience at the University of Minnesota Hospitals. Cancer 1980;45: Kaplan EL, Meier P. Non-parametric estimation from incomplete observatio. J Am Stat Assoc 1958;53: Mantel N. Evaluation of survival data and two new rank order statistics arising in its coideration. Cancer Chemother Rep 1966;50: Cox DR. Regression models and life tables. J R Stat Soc B 1972;34: Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997;113: Cerfolio RJ, Allen MS, Deschamps C, et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 1994;57: Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P. Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 1997;11: Loehe F, Kobinger S, Hatz R, Helmberger T, Loehrs U, Fuerst H. Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy. Ann Thorac Surg 2001;72: Ambrogi V, Paci M, Pompeo E, Mineo TC. Traxiphoid video-assisted pulmonary metastasectomy: relevance of helical computed tomography occult lesio. Ann Thorac Surg 2000;70: McCormack PM, Bai MS, Begg CB, et al. Role of videoassisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 1996;62: McAfee MK, Allen MS, Trastek VF, Ilstrup DM, Deschamps C, Pairolero PC. Colorectal lung metastases: results of surgical excision [see comments]. Ann Thorac Surg 1992;53: Jett JR, Hollinger CG, Zimeister AR, Pairolero PC. Pulmonary resection of metastatic renal cell carcinoma. Chest 1983; 84: Kandioler D, Kromer E, Tuchler H, et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998;65: Maldazys JD, dekernion JB. Prognostic factors in metastatic renal carcinoma. J Urol 1986;136: Robert JH, Ambrogi V, Mermillod B, Dahabreh D, Goldstraw P. Factors influencing long-term survival after lung metastasectomy. Ann Thorac Surg 1997;63: Johen JA, Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 1997;157: Dineen MK, Pastore RD, Emrich LJ, Huben RP. Results of surgical treatment of renal cell carcinoma with solitary metastasis. J Urol 1988;140: Pogrebniak HW, Haas G, Linehan WM, Rosenberg SA, Pass HI. Renal cell carcinoma: resection of solitary and multiple metastases. Ann Thorac Surg 1992;54: Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998;16: Friedel G, Hurtgen M, Penzetadler M, Kyriss T, Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 1999;19:
Prognostic Factors and Survival after Pulmonary Resection ofmetastaticrenalcellcarcinoma
European Urology European Urology 48 (2005) 77 82 Kidney Cancer Prognostic Factors and Survival after Pulmonary Resection ofmetastaticrenalcellcarcinoma Hans-Stefan Hofmann*, Heinz Neef, Katharina Krohe,
More informationPulmonary resection for metastatic colorectal carcinoma was first performed
General Thoracic Surgery Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment Yukihito Saito, MD, a Hideyasu Omiya, MD, a Keijiro Kohno, MD, b Takanobu Kobayashi,
More informationValue of Systematic Mediastinal Lymph Node Dissection During Pulmonary Metastasectomy
Value of Systematic Mediastinal Lymph Node Dissection During Pulmonary Metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A. Hatz, MD, Thomas Helmberger, MD, Udo Loehrs, MD, and Heinrich Fuerst,
More informationPulmonary Resection for Metastases from Colorectal Cancer
ORIGINAL ARTICLE Pulmonary Resection for Metastases from Colorectal Cancer Paul M. van Schaik, MD,* Ewout A. Kouwenhoven, MD, PhD,* Robert J. Bolhuis, MD,* Bonne Biesma, MD, PhD, and Koop Bosscha, MD,
More informationCASE REPORT. Introduction. Case series reports. J Thorac Dis 2012;4(S1): DOI: /j.issn s003
CASE REPORT Lost in time pulmonary metastases of renal cell carcinoma: complete surgical resection of metachronous metastases, 18 and 15 years after nephrectomy Kosmas Tsakiridis 1, Aikaterini N Visouli
More informationThe lungs are the second most frequent site for metastases
Prognostic Factors for Survival After Pulmonary Resection of Metastatic Renal Cell Carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas Muley, PhD, Sabine Krysa, MD, Christine Trainer, MD,
More informationColon cancer is still one of the leading causes of
Long-Term Survival After Repeated Resection of Pulmonary Metastases From Colorectal Cancer Stefan Welter, MD, Jan Jacobs, MD, Thomas Krbek, MD, Bettina Krebs, MD, and Georgios Stamatis, MD Department of
More informationSynchronous pulmonary metastases from renal cell carcinoma a whole nation study on prevalence and potential resectability
Scandinavian Journal of Surgery 101: 160 165, 2012 Synchronous pulmonary metastases from renal cell carcinoma a whole nation study on prevalence and potential resectability S. J. Oddsson 1, S. Hardarson
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationPulmonary resection remains the most effective. Survival in Synchronous vs Single Lung Cancer. Upstaging Better Reflects Prognosis
Survival in Synchronous vs Single Lung Cancer Upstaging Better Reflects Prognosis Marcel Th. M. van Rens, MD; Pieter Zanen, MD, PhD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD;
More informationSurgical Approaches to Pulmonary Metastases
Surgical Approaches to Pulmonary Metastases Raja M Flores MD Professor and Chief Thoracic Surgery Mount Sinai School of Medicine New York, New York History of Lung Metastasectomy 1882 Weinlechner +CW 1926
More informationsarcoma Reprint requests: Dr M H Robinson, YCRC Senior Lecturer Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ.
1994, The British Journal of Radiology, 67, 129-135 Lung metastasectomy sarcoma in patients with soft tissue 1 M H ROBINSON, MD, MRCP, FRCR, 2 M SHEPPARD, FRCPATH, 3 E MOSKOVIC, MRCP, FRCR and 4 C FISHER,
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationMore than half of the patients undergoing resection for colorectal
General Thoracic Surgery Pfannschmidt et al Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,
More informationThe metastatic behavior of renal cell carcinoma (RCC) Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors
Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine Dujon, MD, Christophe Foucault, MD, and Marc Riquet,
More informationVATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS
VATS Metastasectomy Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute Disclosures Speaking & Education:
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationRetroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients
Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients INGO ALLDINGER 1,2, QIN YANG 3, CHRISTIAN PILARSKY 1, HANS-DETLEV SAEGER 1, WOLFRAM T. KNOEFEL
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationSurgical Management of Pulmonary Metastases. Dr AG Jacobs Principal Specialist Dept Cardiothoracic Surgery Steve Biko Academic Hospital
Surgical Management of Pulmonary Metastases Dr AG Jacobs Principal Specialist Dept Cardiothoracic Surgery Steve Biko Academic Hospital Introduction Lungs 2 nd most common site of metastatic deposition
More informationPulmonary Metastasectomy for Pulmonary Metastases of Head and Neck Squamous Cell Carcinomas
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationStandard treatment for pulmonary metastasis of non-small
ORIGINAL ARTICLE Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer Kenichi Okubo, MD,* Toru Bando, MD,* Ryo Miyahara, MD,* Hiroaki Sakai, MD,* Tsuyoshi Shoji, MD,* Makoto Sonobe, MD,* Takuji
More informationPULMONARY RESECTION FOR METASTATIC COLORECTAL CANCER: EXPERIENCES WITH 159 PATIENTS
PULMONARY RESECTION FOR METASTATIC COLORECTAL CANCER: EXPERIENCES WITH 159 PATIENTS Shinji Okumura, MD Haruhiko Kondo, MD Masahiro Tsuboi, MD Haruhiko Nakayama, MD Hisao Asamura, MD Ryosuke Tsuchiya, MD
More informationTreatment of oligometastatic NSCLC
Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic
More information141 Ann Thorac Surg , Aug Copyright by The Society of Thoracic Surgeons
Completion Pneumonectomy: Indications, Complications, and Results Eilis M. McGovern, M.B.B.Ch., Victor F. Trastek, M.D., Peter C. Pairolero, M.D., and W. Spencer Payne, M.D. ABSTRACT From 958 through 985,
More informationComplete surgical excision remains the greatest potential
ORIGINAL ARTICLE Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD,* Charles E. Eastridge, MD, Elizabeth A. Tolley,
More informationThe roles of adjuvant chemotherapy and thoracic irradiation
Factors Predicting Patterns of Recurrence After Resection of N1 Non-Small Cell Lung Carcinoma Timothy E. Sawyer, MD, James A. Bonner, MD, Perry M. Gould, MD, Robert L. Foote, MD, Claude Deschamps, MD,
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationThe prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer
Cho et al. World Journal of Surgical Oncology (2015) 13:222 DOI 10.1186/s12957-015-0621-7 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access The prognostic importance of the number of metastases in
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationPulmonary laser resections: Technical aspects and results in colorectal cancer
Pulmonary laser resections: Technical aspects and results in colorectal cancer Bernward Passlick Professor of Thoracic Surgery Dept. of Thoracic Surgery University of Freiburg Germany Pulmonary laser resections
More informationSurgical treatment in non-small cell lung cancer with pulmonary oligometastasis
He et al. World Journal of Surgical Oncology (2017) 15:36 DOI 10.1186/s12957-017-1105-8 RESEARCH Open Access Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis Jinyuan He,
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationPulmonary metastasectomy in uterine malignancies: outcome and prognostic factors
Original Article Pulmonary metastasectomy in uterine malignancies: outcome and prognostic factors Marco Anile, Sara Mantovani, Ylenia Pecoraro, Carolina Carillo, Lorenzo Gherzi, Andreina Pagini, Erino
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationChirurgie beim oligo-metastatischen NSCLC
24. Ärzte-Fortbildungskurs in Klinischer Onkologie 20.-22. Februar 2014, Kantonsspital St. Gallen Chirurgie beim oligo-metastatischen NSCLC Prof. Dr. med. Walter Weder Klinikdirektor Thoraxchirurgie, UniversitätsSpital
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationSite of Recurrence in Patients. of the Lung Resected for Cure. with Stages I and I1 Carcinoma
Site of Recurrence in Patients with Stages I and I1 Carcinoma of the Lung Resected for Cure Steven C. Immerman, M.D., Robert M. Vanecko, M.D., Willard A. Fry, M.D., Louis R. Head, M.D., and Thomas W. Shields,
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationShort- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer
Original Article Short- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer Takeshi Kawaguchi, MD, Takashi Tojo, MD, Keiji Kushibe, MD, Michitaka Kimura, MD, Yoko Nagata, MD, and Shigeki
More informationPulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience
Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience Clinton D. Kemp, MD,* R. Taylor Ripley, MD,* Aarti Mathur, MD, Seth M. Steinberg, PhD, Dao M. Nguyen,
More informationThe Importance of One-Stage Median Stemotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer
The Importance of One-Stage Median Stemotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer Isidore Mandelbaum, M.D., Peter B. Yaw, M.D., Lawrence H. Einhorn, M.D., Stephen D. Williams,
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationORIGINAL ARTICLE. Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma
ORIGINAL ARTICLE Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma Alexander Rehders, MD; Stefan B. Hosch, MD; Peter Scheunemann, MD; Nikolas H. Stoecklein, MD; Wolfram T. Knoefel,
More informationAggressive Slurgical Management of Testicular Carcinoma Metastatic to Lungs and Mediastinurn
Aggressive Slurgical Management of Testicular Carcinoma Metastatic to Lungs and Mediastinurn Isadore Mandelbaum, M.D., Stephen D. Williams, M.D., and Lawrence H. Einhorn, M.D. ABSTRACT During the past
More informationClinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy
Respiratory Medicine Volume 2015, Article ID 570314, 5 pages http://dx.doi.org/10.1155/2015/570314 Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication
More informationVideo-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative
Surg Endosc (2009) 23:1947 1954 DOI 10.1007/s00464-008-0243-z Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative Marilee Carballo Æ Mary S. Maish
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationMultifocal Lung Cancer
Multifocal Lung Cancer P. De Leyn, MD, PhD Department of Thoracic Surgery University Hospitals Leuven Belgium LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery Department of Pneumology Department
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationMediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma*
Mediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma* Mediastinal Nodal Metastases in Lung Cancer Yoh Watanabe, M.D., F.C.C.P.; ]unzo Shimizu, M.D.; Makoto Tsubota, M.D.; and Takashi
More informationRoutine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF)
Routine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF) Abstract The results of 25 cases underwent a pedicled pericardial flap coverage for the bronchial
More informationIn the past, pulmonary metastases (PM) were considered
Original Article The Role of Extended Pulmonary Metastasectomy Monica Casiraghi, MD,* Patrick Maisonneuve, Eng, Daniela Brambilla, Msc,* Francesco Petrella, MD,* Piergiorgio Solli, MD,* Juliana Guarize,
More informationGUIDELINES ON RENAL CELL CARCINOMA
GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists
More informationIn 2004, approximately 55,100 people in the United States were diagnosed with
Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, a Steven I. Hanish, MD, a John C. Haney, MD, a Charles C.
More informationThe pathophysiology of pulmonary metastases is initiated
Surgical Management of Pulmonary Metastases Loretta Erhunmwunsee, MD, and Thomas A. D Amico, MD Department of Surgery, Duke University Medical Center, Durham, North Carolina Metastasectomy is the only
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More informationTHORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationMultidisciplinary management of retroperitoneal sarcomas
Multidisciplinary management of retroperitoneal sarcomas Eric K. Nakakura, MD UCSF Department of Surgery UCSF Comprehensive Cancer Center San Francisco, CA 7 th Annual Clinical Cancer Update North Lake
More informationDespite their reputation of benignity, carcinoid tumors
Operative Risk and Prognostic Factors of Typical Bronchial Carcinoid Tumors Xavier Ducrocq, MD, Pascal Thomas, MD, Gilbert Massard, MD, Pierre Barsotti, MD, Roger Giudicelli, MD, Pierre Fuentes, MD, and
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationTristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease
Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately
More informationAdjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals
6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationSurgery for early stage NSCLC
1-3 March 2017, Manchester, UK Surgery for early stage NSCLC Dominique H. Grunenwald, MD, PhD Professor Emeritus in Thoracic and Cardiovascular surgery Pierre & Marie Curie University. Paris. France what
More informationTreatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer
Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer Ryoichi Nakanishi, MD, Toshihiro Osaki, MD, Kozo Nakanishi, MD, Ichiro Yoshino, MD, Takashi Yoshimatsu,
More informationBone Metastases in Muscle-Invasive Bladder Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer
More informationGUIDELINES ON RENAL CELL CANCER
20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance
More informationORIGINAL RESEARCH. International Journal of Surgery
International Journal of Surgery 11 (2013) 244e248 Contents lists available at SciVerse ScienceDirect International Journal of Surgery journal homepage: www.theijs.com Original research Pulmonary metastasectomy
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationGerm cell tumors (GCT) are uncommon neoplasms
ORIGINAL ARTICLES: GENERAL THORACIC Pulmonary Metastasectomy for Testicular Germ Cell Tumors: A 28-Year Experience David Liu, MD, Amir Abolhoda, MD, Michael E. Burt, MD, PhD, Nael Martini, MD, Manjit S.
More informationPolypoid Gallbladder Lesion in the Context of Renal Cell Carcinoma: Is Laparoscopic Cholecystectomy a Reasonable Option?
499008HICXXX10.1177/2324709613499008Journal of Investigative Medicine High Impact Case Reports 1(3)Seeliger et al research-article2013 Case Report Polypoid Gallbladder Lesion in the Context of Renal Cell
More informationFDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
More informationTumour size as a prognostic factor after resection of lung carcinoma
Tumour size as a prognostic factor after resection of lung carcinoma A. S. SOORAE AND R. ABBEY SMITH Thorax, 1977, 32, 19-25 From the Cardio-Thoracic Unit, Walsgrave Hospital, Clifford Bridge Road, Coventry
More informationRelevance of an Intensive Postoperative Follow-up After Surgery for Non Small Cell Lung Cancer
Relevance of an Intensive Postoperative Follow-up After Surgery for Non Small Cell Lung Cancer Virginie Westeel, MD, Didier Choma, MD, François Clément, MD, Marie-Christine Woronoff-Lemsi, PhD, Jean-François
More informationResected Synchronous Primary Malignant Lung Tumors: A Population-Based Study
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationHistopathologic Prognostic Factors in Resected Colorectal Lung Metastases
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Yukinori Murata, MT, Koji Tsuta,
More informationDoppler ultrasound of the abdomen and pelvis, and color Doppler
- - - - - - - - - - - - - Testicular tumors are rare in children. They account for only 1% of all pediatric solid tumors and 3% of all testicular tumors [1,2]. The annual incidence of testicular tumors
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationGuidelines on Renal Cell
Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma
More information24 Ann Thorac Surg 46:24-28, July Copyright by The Society of Thoracic Surgeons
Surgical Management of Lung Cancer with Solitary Cerebral Metastasis John R. Hankins, M.D., John E. Miller, M.D., Michael Salcman, M.D., Frank Ferraro, M.D., David C. Green, M.D., Safuh Attar, M.D., and
More informationcame from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
More informationMEDIASTINAL STAGING surgical pro
MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical
More informationM expected to arise in 1.6% to 3.0% of all patients. Multiple Primary Lung Carcinomas: Prognosis and Treatment
Multiple Primary Lung Carcinomas: Prognosis and Treatment Todd K. Rosengart, MD, Nael Martini, MD, Pierre Ghosn, MD, and Michael Burt, MD, PhD Thoracic Service, Department of Surgery, Memorial-Sloan Kettering
More informationSurgical Treatment for Pulmonary Me. Tsunehisa; Kugimiya, Toshiyasu. Citation Acta medica Nagasakiensia. 1983, 28
NAOSITE: Nagasaki University's Ac Title Author(s) Surgical Treatment for Pulmonary Me Ayabe, Hiroyoshi; Tomita, Masao; Na Katsunobu; Nakao, Susumu; Eguchi, M Tsunehisa; Kugimiya, Toshiyasu Citation Acta
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More information1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/23566
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Mesothelioma: Live to Fight Another Day Andrea S. Wolf, MD, Raja M. Flores, MD PII: S0022-5223(17)32747-2 DOI: 10.1016/j.jtcvs.2017.11.060 Reference: YMTC 12301 To appear in: The Journal
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More information